Bruno Bockorny, MD

Dr. Bruno Bockorny is an academic medical oncologist with a focus on clinical trials and early-phase drug development for patients with advanced solid tumors. He is an Assistant Professor of Medicine at Harvard Medical School and serves as a staff medical oncologist and Clinical Director of the Phase 1 Clinical Trials Program at Beth Israel Deaconess Medical Center, a major teaching affiliate of Harvard.

In these roles, Dr. Bockorny has led over 20 clinical trials as Principal Investigator, including investigator-initiated, NIH-funded, and industry-sponsored studies. His research centers on uncovering mechanisms of resistance to immunotherapy, with the goal of developing more effective, durable cancer treatments. His work has been published in leading journals such as Nature Medicine and Clinical Cancer Research.

Dr. Bockorny is the recipient of several honors, including the prestigious Young Investigator Award from the American Society of Clinical Oncology. His long-term mission is to help bring forward practice-changing therapies that improve outcomes for patients with hard-to-treat cancers.

Like so many others, Dr. Bockorny has felt the impact of cancer within his own family—a personal experience that continues to shape his unwavering commitment to advancing care and support for all patients.

​

​